Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FDG-PET Based Chemotherapy Selection for Metastatic Non-Small Cell Lung Cancer

NCT00564733 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT00564733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00564733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FDG-PET Based Chemotherapy Selection for Metastatic Non-Small Cell Lung Cancer
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
March 31, 2012
Enrollment
55 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural effusion, stage iiib non-small cell lung cancer, stage iv non-small cell lung cancer